$INVA
Innoviva Inc Stock $inva

$inva Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000104746914001691 Filed on March 03, 2014

Income Statement

Concept	2014 Q1	2013 Q4	2013
Revenue	$165.0K	$1.500M	$4.758M
YoY Change	-87.72%	-74.14%	-96.5%
Cost Of Revenue	$188.0K
YoY Change
Gross Profit	-$23.00K
YoY Change	-101.71%
Gross Profit Margin	-13.94%
Selling, General & Admin	$22.83M	$6.400M	$48.44M
YoY Change	174.61%	-16.88%	56.97%
% of Gross Profit
Research & Development	$43.39M	$2.500M	$125.2M
YoY Change	64.25%	-91.1%	6.18%
% of Gross Profit
Depreciation & Amortization	$3.400M	-$2.200M	$8.203M
YoY Change	79.14%	0.0%	11.97%
% of Gross Profit
Operating Expenses	$66.41M	$8.900M	$173.6M
YoY Change	91.21%	-75.14%	16.71%
Operating Profit	-$66.24M		-$168.9M
YoY Change	98.41%		1199.05%
Interest Expense	$1.644M	-$1.500M	$9.348M
YoY Change	-39.91%	15.38%	55.72%
% of Operating Profit
Other Income/Expense, Net	-$3.000K	$0.00	$6.732M
YoY Change	-99.79%
Pretax Income	-$16.20M	-$8.900M	-$30.60M
YoY Change	51.4%	-71.57%	65.41%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$67.70M	-$49.90M	-$170.7M
YoY Change	81.02%	59.42%	822.7%
Net Earnings / Revenue	-41030.3%	-3326.67%	-3587.64%
Basic Earnings Per Share
Diluted Earnings Per Share	-$611.6K	-$459.1K	-$1.667M
COMMON SHARES
Basic Shares Outstanding	112.0M shares	110.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013 Q4	2013
SHORT-TERM ASSETS
Cash & Short-Term Investments	$370.9M	$465.1M	$465.1M
YoY Change	-19.2%	87.18%	87.16%
Cash & Equivalents	$125.3M	$143.5M	$143.5M
Short-Term Investments	$245.6M	$321.6M	$321.6M
Other Short-Term Assets	$6.400M	$4.300M	$4.300M
YoY Change	23.08%	7.5%	7.5%
Inventory	$11.01M	$10.41M	$10.40M
Prepaid Expenses
Receivables	$3.000K	$199.0K	$3.400M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$389.2M	$483.2M	$483.2M
YoY Change	-17.98%	85.04%	85.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.734M	$10.24M	$10.20M
YoY Change	8.04%	11.84%	10.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$59.80M	$55.40M	$55.40M
YoY Change	-39.78%	-41.81%	-41.81%
Other Assets	$7.963M	$7.355M	$8.200M
YoY Change	3.66%	224.29%	173.33%
Total Long-Term Assets	$215.8M	$198.1M	$198.1M
YoY Change	84.47%	84.33%	84.28%
TOTAL ASSETS
Total Short-Term Assets	$389.2M	$483.2M	$483.2M
Total Long-Term Assets	$215.8M	$198.1M	$198.1M
Total Assets	$605.0M	$681.3M	$681.3M
YoY Change	2.28%	84.83%	84.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.546M	$7.583M	$47.60M
YoY Change	57.33%	41.03%	781.48%
Accrued Expenses	$29.80M	$27.50M	$27.50M
YoY Change	85.09%	37.5%	37.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$44.14M	$84.40M	$84.40M
YoY Change	49.82%	181.67%	181.33%
LONG-TERM LIABILITIES
Long-Term Debt	$287.5M	$287.5M	$287.5M
YoY Change	-37.5%	66.67%	66.67%
Other Long-Term Liabilities	$10.10M	$0.00	$10.20M
YoY Change	-3.81%	-100.0%	-8.11%
Total Long-Term Liabilities	$297.6M	$0.00	$297.7M
YoY Change	-36.75%	-100.0%	62.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.14M	$84.40M	$84.40M
Total Long-Term Liabilities	$297.6M	$0.00	$297.7M
Total Liabilities	$341.8M	$84.40M	$382.1M
YoY Change	-31.64%	-60.49%	78.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.573B	-$1.505B
YoY Change	14.65%	12.79%
Common Stock	$1.836B	$1.804B
YoY Change	25.47%	21.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$263.3M	$299.1M	$299.1M
YoY Change
Total Liabilities & Shareholders Equity	$605.0M	$681.3M	$681.3M
YoY Change	2.28%	84.83%	84.83%

Cashflow Statement

Concept	2014 Q1	2013 Q4	2013
OPERATING ACTIVITIES
Net Income	-$67.70M	-$49.90M	-$170.7M
YoY Change	81.02%	59.42%	822.7%
Depreciation, Depletion And Amortization	$3.400M	-$2.200M	$8.203M
YoY Change	79.14%	0.0%	11.97%
Cash From Operating Activities	-$50.60M	-$40.00M	-$129.6M
YoY Change	60.13%	65.29%	1.65%
INVESTING ACTIVITIES
Capital Expenditures	$1.620M	-$46.00M	$2.734M
YoY Change	118.92%	15233.33%	5.56%
Acquisitions
YoY Change
Other Investing Activities	$70.80M	$44.70M	-$131.8M
YoY Change	-259.82%	11075.0%	136.62%
Cash From Investing Activities	$14.10M	-$1.400M	-$219.6M
YoY Change	-131.33%	-1500.0%	276.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$18.27M		$153.0M
YoY Change	510.9%		-35.26%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	18.30M	13.00M	397.8M
YoY Change	-92.62%	91.18%	68.63%
NET CHANGE
Cash From Operating Activities	-50.60M	-40.00M	-129.6M
Cash From Investing Activities	14.10M	-1.400M	-219.6M
Cash From Financing Activities	18.30M	13.00M	397.8M
Net Change In Cash	-18.20M	-28.40M	48.60M
YoY Change	-110.62%	64.16%	-2.99%
FREE CASH FLOW
Cash From Operating Activities	-$50.60M	-$40.00M	-$129.6M
Capital Expenditures	$1.620M	-$46.00M	$2.734M
Free Cash Flow	-$52.22M	$6.000M	-$132.3M
YoY Change	61.47%	-125.1%	1.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	thrx	Number Of Independent Publicly Traded Companies Created By Separation Of Businesses As Approved By Board Of Directors NumberOfIndependentPubliclyTradedCompaniesCreatedBySeparationOfBusinessesAsApprovedByBoardOfDirectors	2	Item
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	833000	USD
CY2012Q4	thrx	Receivables From Collaboration Partners ReceivablesFromCollaborationPartners	1064000	USD
CY2013	thrx	Period Over Which Annual Rent Expense Exceeded Actual Cash Rent Payment PeriodOverWhichAnnualRentExpenseExceededActualCashRentPayment	P1Y6M
CY2013Q4	us-gaap	Incentive To Lessee IncentiveToLessee	2600000	USD
CY2013Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10000000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>Use of Management's Estimates</i></b></font></p> <p style="FONT-FAMILY: times;"><font size="2">        The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, management evaluates its significant accounting policies and estimates. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. These estimates also form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources.</font></p> </div>
CY2011	thrx	Collaborative Arrangement Research And Development Expenses Reimbursed To Entity CollaborativeArrangementResearchAndDevelopmentExpensesReimbursedToEntity	839000	USD
CY2013	thrx	Collaborative Arrangement Research And Development Expenses Reimbursed To Entity CollaborativeArrangementResearchAndDevelopmentExpensesReimbursedToEntity	6996000	USD
CY2012	thrx	Collaborative Arrangement Research And Development Expenses Reimbursed To Entity CollaborativeArrangementResearchAndDevelopmentExpensesReimbursedToEntity	1109000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-170701000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18542000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-115344000	USD
CY2013	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	104789000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	93410000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	84493000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2364000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2501000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2442000	shares
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.67
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.41
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6875000	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12035000	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12132000	shares
CY2013	thrx	Collaborative Arrangements Revenue CollaborativeArrangementsRevenue	3556000	USD
CY2012	thrx	Collaborative Arrangements Revenue CollaborativeArrangementsRevenue	135758000	USD
CY2011	thrx	Collaborative Arrangements Revenue CollaborativeArrangementsRevenue	24512000	USD
CY2011	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	THERAVANCE INC
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001080014
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	111976127	shares
CY2013Q2	dei	Entity Public Float EntityPublicFloat	1657233711	USD
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94849000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	153640000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	55374000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4066000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	7514000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	261133000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	95194000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	833000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9154000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7355000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2268000	USD
CY2012Q4	us-gaap	Assets Assets	368582000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5377000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9002000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6550000	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2372000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2072000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4593000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29966000	USD
CY2012Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	172500000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	5074000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6014000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1488447000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	99000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1334502000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	155028000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	368582000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	199000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	124257000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	84404000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	483198000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	299122000	USD
CY2012Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	123000	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	2247000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2013	us-gaap	Operating Expenses OperatingExpenses	173621000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-168863000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	117898000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	103568000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30859000	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30681000	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	148757000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	134249000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-12999000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-109737000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6732000	USD
CY2012	us-gaap	Investment Income Net InvestmentIncomeNet	460000	USD
CY2011	us-gaap	Investment Income Net InvestmentIncomeNet	415000	USD
CY2012	us-gaap	Interest Expense InterestExpense	6003000	USD
CY2011	us-gaap	Interest Expense InterestExpense	6022000	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	102425000	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	90909000	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	82051000	shares
CY2013	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3330000	USD
CY2012	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	5613000	USD
CY2011	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	9658000	USD
CY2013	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	63000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-170638000	USD
CY2012	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	83000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18459000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-115361000	USD
CY2011	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-17000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-22420000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-87052000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7081000	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12195000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	26991000	USD
CY2011	thrx	Stock Issued During Period Value Private Placement To Related Party StockIssuedDuringPeriodValuePrivatePlacementToRelatedParty	13618000	USD
CY2013	thrx	Stock Issued During Period Value Private Placement To Related Party StockIssuedDuringPeriodValuePrivatePlacementToRelatedParty	126030000	USD
CY2012	thrx	Stock Issued During Period Value Private Placement To Related Party StockIssuedDuringPeriodValuePrivatePlacementToRelatedParty	229296000	USD
CY2011	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	24916000	USD
CY2013	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	25858000	USD
CY2012	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	24162000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	63000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8203000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	83000	USD
CY2012	thrx	Adjustments To Additional Paid In Capital Stock Issued Private Placement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedPrivatePlacementIssuanceCosts	400000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25808000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	236377000	USD
CY2013	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	36800000	USD
CY2013	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	281622000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	235867000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	25602000	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	50071000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-118555000	USD
CY2012	us-gaap	Interest Paid InterestPaid	5177000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7326000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	23783000	USD
CY2012	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	-441000	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1422000	USD
CY2012	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	841000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	441000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4822000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1480000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1829000	USD
CY2013	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	-428000	USD
CY2012	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	747000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-130107000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-127513000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7583000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	24916000	USD
CY2011	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	29000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2288000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3310000	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5124000	USD
CY2011	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-2429000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-18633000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-88338000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-129602000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-219580000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	397843000	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	48661000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2590000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3628000	USD
CY2011	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	301563000	USD
CY2012	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	330484000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	224902000	USD
CY2012	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	49729000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-60000	USD
CY2012	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	140000	USD
CY2012	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	240000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-58283000	USD
CY2011	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	231476000	USD
CY2011	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	17321000	USD
CY2011	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	140000	USD
CY2011	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	715000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-55819000	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	85000000	USD
CY2012	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	69000	USD
CY2011	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	206000	USD
CY2011	us-gaap	Interest Paid InterestPaid	5195000	USD
CY2013	us-gaap	Interest Paid InterestPaid	7970000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44778000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163333000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	143510000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	502669000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	335866000	USD
CY2013Q4	thrx	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	172000	USD
CY2012Q4	thrx	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	127000	USD
CY2013Q4	thrx	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	10000	USD
CY2012Q4	thrx	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	28000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	502831000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	335965000	USD
CY2013	thrx	Marketable Securities Maximum Contractual Maturity Period MarketableSecuritiesMaximumContractualMaturityPeriod	P2Y
CY2013	thrx	Marketable Securities Average Contractual Maturity Period MarketableSecuritiesAverageContractualMaturityPeriod	P7M
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5138000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5668000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	360000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	565000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	10406000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4908000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	58574000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	62044000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49420000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51806000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10238000	USD
CY2013	us-gaap	Depreciation Depreciation	2700000	USD
CY2012	us-gaap	Depreciation Depreciation	3300000	USD
CY2011	us-gaap	Depreciation Depreciation	3800000	USD
CY2012	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	200000	USD
CY2013Q4	thrx	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	44000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	33000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	591000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	521000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	70100000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3000000	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	50000000	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0421	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.0167	pure
CY2012	thrx	Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationCost	-0.1324	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0136	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0032	pure
CY2012	thrx	Effective Income Tax Rate Reconciliation Net Operating Loss Expiration EffectiveIncomeTaxRateReconciliationNetOperatingLossExpiration	-0.0181	pure
CY2011	thrx	Effective Income Tax Rate Reconciliation Net Operating Loss Expiration EffectiveIncomeTaxRateReconciliationNetOperatingLossExpiration	-0.0042	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0209	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0075	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1129	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3568	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.0363	pure
CY2013	thrx	Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationCost	-0.0007	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0028	pure
CY2013	thrx	Effective Income Tax Rate Reconciliation Net Operating Loss Expiration EffectiveIncomeTaxRateReconciliationNetOperatingLossExpiration	0.0000	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0251	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3533	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	46900000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	52500000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	42600000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	57420000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5600000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4300000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7100000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8100000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8100000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	8100000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	8100000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	84700000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2011	thrx	Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationCost	0.0000	pure
CY2012Q4	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0	USD
CY2012Q4	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0	USD
CY2012Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2012Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2013	us-gaap	Interest Expense InterestExpense	9348000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	25687000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2013	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	200000	USD
CY2012	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	400000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25687000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23783000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24916000	USD
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	56316000	USD
CY2013Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	287500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	479000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	411000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	6000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4000000	USD
CY2013Q4	thrx	Deferred Tax Assets Capitalized Research And Development Expenses DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses	30000000	USD
CY2012Q4	thrx	Deferred Tax Assets Capitalized Research And Development Expenses DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses	35000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5485000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	321615000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000000	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.04
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27700000	USD
CY2013Q4	thrx	Receivables From Collaboration Partners ReceivablesFromCollaborationPartners	3181000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4287000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	USD
CY2013Q4	us-gaap	Assets Assets	681255000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7583000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10881000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9714000	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2800000	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4137000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9289000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4774000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5455000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1803048000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	162000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1505203000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	681255000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2012Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1846000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	125181000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48440000	USD
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	778000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	578000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1613000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5850000	USD
CY2013	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	299000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3235000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2734000	USD
CY2013	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	410407000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	255861000	USD
CY2013	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2117000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-36000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3100000	USD
CY2013	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	22600000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2013	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2013	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	100000	USD
CY2013	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	153021000	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	172499000	USD
CY2012Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	USD
CY2013Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	89000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	0	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	89000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0	USD
CY2013Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	40000000	USD
CY2012Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	743000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2013	us-gaap	Revenues Revenues	4758000	USD
CY2012	us-gaap	Revenues Revenues	135758000	USD
CY2011	us-gaap	Revenues Revenues	24512000	USD
CY2013	thrx	Adjustments To Capped Call Options Associated With Convertible Subordinated Notes Due2023 AdjustmentsToCappedCallOptionsAssociatedWithConvertibleSubordinatedNotesDue2023	35378000	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
CY2012	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2011	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	171231000	USD
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-17000	USD
CY2012	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-187000	USD
CY2011	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-18000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-702000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2011	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2012	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2011	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2012	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	0	USD
CY2011	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	0	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2011	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2012	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2011	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	0	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2013	thrx	Royalty Revenue From Related Party Net RoyaltyRevenueFromRelatedPartyNet	1202000	USD
CY2012	thrx	Royalty Revenue From Related Party Net RoyaltyRevenueFromRelatedPartyNet	0	USD
CY2011	thrx	Royalty Revenue From Related Party Net RoyaltyRevenueFromRelatedPartyNet	0	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2012	us-gaap	Advertising Expense AdvertisingExpense	0	USD
CY2011	us-gaap	Advertising Expense AdvertisingExpense	0	USD
CY2013	thrx	Other Income Expense Net OtherIncomeExpenseNet	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>Other Income (Expense), net</i></b></font></p> <p style="FONT-FAMILY: times;"><font size="2">        In May 2013, we entered into a royalty participation agreement with Elan Corporation, plc ("Elan"). The closing of the transaction was subject to closing conditions, including the approval of the transaction by Elan's shareholders. Elan's shareholders did not approve the transaction at an Extraordinary General Meeting. Subsequently, we terminated the agreement and, as a result, Elan paid us a $10.0 million termination fee in June 2013, which is reflected in other income on the consolidated statements of operations. Other expense is comprised of third party expenses related to the aforementioned royalty participation agreement and the change in the estimated fair value of the capped-call instruments related to our convertible subordinated notes issued in January 2013, which is reflected in other expense.</font></p> </div>
CY2013	thrx	Concentration Of Credit And Other Risks ConcentrationOfCreditAndOtherRisks	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>Concentration of Credit and Other Risks</i></b></font></p> <p style="FONT-FAMILY: times;"><font size="2">        We invest in a variety of financial instruments and, by our policy, limit the amount of credit exposure with any one issuer, industry or geographic area for investments other than instruments backed by the U.S. federal government.</font></p> <p style="FONT-FAMILY: times;"><font size="2">        Our accounts receivable at December 31, 2013, represent amounts due to us from distributors. The following table summarizes accounts receivable, net balances at December 31, 2013 by distributor:</font></p> <div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"> <p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p> <!-- User-specified TAGGED TABLE --> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"> <tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET --> <td style="FONT-FAMILY: times;" align="left"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="93"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="93"></td> <td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr> <tr style="padding:0;" valign="bottom"> <th style="FONT-FAMILY: times;" nowrap="nowrap" align="left"> <div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 40pt; MARGIN-BOTTOM: 0pt;"><font size="1"><b>Distributor <!-- COMMAND=ADD_SCROPPEDRULE,40pt --></b></font></div></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Accounts Receivable<br /> (In thousands)</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Percentage of Total<br /> Accounts Receivable<br /> Balance</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th></tr> <tr style="padding:0;" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times;" valign="bottom"> <p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">McKesson Corporation</font></p></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">132</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">66</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td></tr> <tr style="padding:0;" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times;" valign="bottom"> <p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">AmerisourceBergen Drug Corporation</font></p></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">66</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">33</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td></tr> <tr style="padding:0;" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times;" valign="bottom"> <p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Other</font></p></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td></tr> <tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td></tr> <tr style="padding:0;" valign="top" bgcolor="#ffffff"> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td></tr> <tr style="padding:0;" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times;" valign="bottom"> <p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total</font></p></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">199</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">100</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td></tr> <tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td></tr> <tr style="padding:0;" valign="top" bgcolor="#ffffff"> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"></td> <td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"></td></tr> <tr style="padding:0;" valign="top" bgcolor="#ffffff"> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font></td> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"></td> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"></td> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"></td> <td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"></td></tr> <tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"> </td> <td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"> </td></tr></table></div> <!-- end of user-specified TAGGED TABLE --></div> <p style="FONT-FAMILY: times;"><font size="2">        We depend on a single-source supplier of the API in VIBATIV® and one supplier to provide fill-finish services related to the manufacturing of VIBATIV®. If any of our suppliers were to limit or terminate production or otherwise fail to meet the quality or delivery requirements needed to supply VIBATIV® at levels to meet market demand, we could experience a loss of revenue, which could materially and adversely impact our results of operations.</font></p> </div>
CY2013	us-gaap	Advertising Expense AdvertisingExpense		USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	591000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	521000000	USD
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares

Files In Submission

Name	View Source	Status
0001047469-14-001691-index-headers.html	Edgar Link	pending
0001047469-14-001691-index.html	Edgar Link	pending
0001047469-14-001691.txt	Edgar Link	pending
0001047469-14-001691-xbrl.zip	Edgar Link	pending
a2218387z10-k.htm	Edgar Link	pending
a2218387zex-10_13.htm	Edgar Link	pending
a2218387zex-23_1.htm	Edgar Link	pending
a2218387zex-31_1.htm	Edgar Link	pending
a2218387zex-31_2.htm	Edgar Link	pending
a2218387zex-32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g198973.jpg	Edgar Link	pending
g959266.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thrx-20131231.xml	Edgar Link	completed
thrx-20131231.xsd	Edgar Link	pending
thrx-20131231_cal.xml	Edgar Link	unprocessable
thrx-20131231_def.xml	Edgar Link	unprocessable
thrx-20131231_lab.xml	Edgar Link	unprocessable
thrx-20131231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INVA
Innoviva Inc Stock $inva

2014 Q1 Form 10-K Financial Statement

#000104746914001691 Filed on March 03, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVA Innoviva Inc Stock $inva

2014 Q1 Form 10-K Financial Statement

#000104746914001691 Filed on March 03, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVA
Innoviva Inc Stock $inva